Results 31 to 40 of about 53,718 (156)

Novel Drug Design for Treatment of COVID‐19: A Systematic Review of Preclinical Studies

open access: yesCanadian Journal of Infectious Diseases and Medical Microbiology, Volume 2022, Issue 1, 2022., 2022
Background. Since the beginning of the novel coronavirus (SARS‐CoV‐2) disease outbreak, there has been an increasing interest in discovering potential therapeutic agents for this disease. In this regard, we conducted a systematic review through an overview of drug development (in silico, in vitro, and in vivo) for treating COVID‐19. Methods.
Sarah Mousavi   +4 more
wiley   +1 more source

Development and Validation of the HPLC Method for Quantification of the Innovative Drug DD217, Factor Xa Inhibitor, in Rat Plasma for a Pharmacokinetic Study

open access: yesРазработка и регистрация лекарственных средств, 2022
Introduction. Nowadays, discovery and development of innovative drugs represent a relevant goal for the pharmaceutical market. One of such drugs is N-(5-chloropyridine-2-yl)-2-({4-[ethanimidoyl(methyl)benzoyl}amino)-5-methylbenzamide hydrochloride ...
N. S. Dubovik   +6 more
doaj   +1 more source

Current Trends on Solid Dispersions: Past, Present, and Future

open access: yesAdvances in Pharmacological and Pharmaceutical Sciences, Volume 2022, Issue 1, 2022., 2022
Solid dispersions have achieved significant interest as an effective means of enhancing the dissolution rate and thus the bioavailability of a range of weakly water‐soluble drugs. Solid dispersions of weakly water‐soluble drugs with water‐soluble carriers have lowered the frequency of these problems and improved dissolution.
Ruba Malkawi   +4 more
wiley   +1 more source

The β-blocker Nebivolol Is a GRK/β-arrestin Biased Agonist [PDF]

open access: yes, 2013
Nebivolol, a third generation β-adrenoceptor (β-AR) antagonist (β-blocker), causes vasodilation by inducing nitric oxide (NO) production. The mechanism via which nebivolol induces NO production remains unknown, resulting in the genesis of much of the ...
Jackson, Edwin K.   +36 more
core   +2 more sources

THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors

open access: yesBritish Journal of Pharmacology, Volume 178, Issue S1, Page S27-S156, October 2021., 2021
The Concise Guide to PHARMACOLOGY 2021/22 is the fifth in this series of biennial publications. The Concise Guide provides concise overviews, mostly in tabular format, of the key properties of nearly 1900 human drug targets with an emphasis on selective pharmacology (where available), plus links to the open access knowledgebase source of drug targets ...
Stephen P H Alexander   +154 more
wiley   +1 more source

The Influence of Menopause and Inflammation on Redox Status and Bone Mineral Density in Patients with Rheumatoid Arthritis

open access: yesOxidative Medicine and Cellular Longevity, Volume 2021, Issue 1, 2021., 2021
Although oxidative stress is considered to be one of the key pathogenic factors in rheumatoid arthritis (RA), there is insufficient knowledge regarding the impact of menopause on redox status in this population. Thus, this study is aimed at assessing the influence of menopause within healthy women and within RA patients as well as the impact of RA in ...
Aleksandra Stojanovic   +9 more
wiley   +1 more source

Long-Term Consequences of Misdiagnosis of Parathyroid Adenomas in Pediatric Patients. [PDF]

open access: yesCase Rep Pediatr
Primary hyperparathyroidism (PHPT) is rare in children but exhibits a more dynamic course than in adults, often leading to multiorgan complications if diagnosis is delayed. This article aims to highlight diagnostic challenges of parathyroid adenomas in children and discuss associated complications from delayed diagnosis.
Roztoczyńska D   +6 more
europepmc   +2 more sources

Effect of Hydroxypropyl Methylcellulose and Microcrystalline Cellulose in Design and Optimization of Nebivolol Hydrochloride Immediate Release Tablets by Response Surface Methodology [PDF]

open access: yes, 2021
The goal of the research is to design and optimize Nebivolol Hydrochloride immediate-release tablet using response surface methodology. Nebivolol Hydrochloride immediate-release tablets used in the treatment of heart attacks, myocardial infarction ...
Jithendra, Chimakurthy   +5 more
core   +1 more source

Experimental design approach for development of novel microemulsion system and immediate release self microemulsifying tablet of nebivolol HCl

open access: yesBrazilian Journal of Pharmaceutical Sciences, 2020
The objective of this study was to determine specific combination of pharmaceutical excipients that lead to formulation of efficient nebivolol hydrochloride SMEDDS and its subsequent formulation into IR-SET (Immediate release- Self emulsifying tablet ...
Hemangi Ramesh Trivedi   +2 more
doaj   +1 more source

l-Nebiviololinium chloride dihydrate

open access: yesActa Crystallographica Section E, 2008
The hydrochloride salt of chiral l-nebivolol {systematic name: (+)−(R,S,S,S)-bis[2-(6-fluoro-3,4-dihydro-2H-1-benzopyran-2-yl)-2-hydroxyethyl]ammonium chloride dihydrate}, C22H26F2NO4+·Cl−·2H2O, was obtained by chiral liquid ...
Andre Hänsicke   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy